Cargando…
Engineered Monoclonal Antibody with Novel Antigen-Sweeping Activity In Vivo
Monoclonal antibodies are widely used to target disease-related antigens. However, because conventional antibody binds to the antigen but cannot eliminate the antigen from plasma, and rather increases the plasma antigen concentration by reducing the clearance of the antigen, some clinically importan...
Autores principales: | Igawa, Tomoyuki, Maeda, Atsuhiko, Haraya, Kenta, Tachibana, Tatsuhiko, Iwayanagi, Yuki, Mimoto, Futa, Higuchi, Yoshinobu, Ishii, Shinya, Tamba, Shigero, Hironiwa, Naoka, Nagano, Kozue, Wakabayashi, Tetsuya, Tsunoda, Hiroyuki, Hattori, Kunihiro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3646756/ https://www.ncbi.nlm.nih.gov/pubmed/23667591 http://dx.doi.org/10.1371/journal.pone.0063236 |
Ejemplares similares
-
Calcium-dependent antigen binding as a novel modality for antibody recycling by endosomal antigen dissociation
por: Hironiwa, N, et al.
Publicado: (2015) -
Identification of human IgG1 variant with enhanced FcRn binding and without increased binding to rheumatoid factor autoantibody
por: Maeda, Atsuhiko, et al.
Publicado: (2017) -
Long lasting neutralization of C5 by SKY59, a novel recycling antibody, is a potential therapy for complement-mediated diseases
por: Fukuzawa, Taku, et al.
Publicado: (2017) -
Novel asymmetrically engineered antibody Fc variant with superior FcγR binding affinity and specificity compared with afucosylated Fc variant
por: Mimoto, Futa, et al.
Publicado: (2013) -
Estimation of Clearance and Bioavailability of Therapeutic Monoclonal Antibodies from Only Subcutaneous Injection Data in Humans Based on Comprehensive Analysis of Clinical Data
por: Haraya, Kenta, et al.
Publicado: (2021)